Send us Feedback

Qlt Inc (QLT)
Analysis
SUMMARY
BULLS
BEARS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
QLT Inc. (QLTI) Reports Statistically Significant Data from L-PPDS Phase 2
StreetInsider.com  Aug 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/QLT+Inc.+%28QLTI%29+Reports+Statistically+Significant+Data+from+L-PPDS+Phase+2/6747234.html for the full story.
QLT Inc. (QLTI) Reports Positive QLT091001 Phase 1b Results
StreetInsider.com  May 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/QLT+Inc.+%28QLTI%29+Reports+Positive+QLT091001+Phase+1b+Results/6465285.html for the full story.
QLT fourth-quarter net loss plummets to $19 million on fewer eye drug sales
Canadian Business  Mar 1  Comment 
VANCOUVER - Drug maker QLT Inc. (TSX:QLT) posted a net loss of US$19.2 million in the fourth quarter compared with a profit of $80,582 in the same
QLT, Inc. (QLTI) Announces 3.62M Common Buyback
StreetInsider.com  Dec 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Stock+Buybacks/QLT%2C+Inc.+%28QLTI%29+Announces+3.62M+Common+Buyback/6150037.html for the full story.
QLT Inc. (QLTI) Announces QLT091001 Granted Orphan Drug Designation by the U.S. FDA
StreetInsider.com  Dec 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/QLT+Inc.+%28QLTI%29+Announces+QLT091001+Granted+Orphan+Drug+Designation+by+the+U.S.+FDA/6148845.html for the full story.
Sales of QLT's main product weaken, company posts loss, lowers 2010 targets
Canadian Business  Nov 3  Comment 
VANCOUVER - Biotechnology developer QLT Inc. (TSX:QLT) lowered its 2010 revenue target by about 12 per cent on Wednesday as the outlook for its
QLT Inc. (QLTI) Tops Q3 Views on Lighter Revs
StreetInsider.com  Nov 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/+QLT+Inc.+%28QLTI%29+Tops+Q3+Views+on+Lighter+Revs/6071540.html for the full story.
QLT Announces Expansion of Phase 1b Study of Oral Synthetic Retinoid Compound
Globe Newswire  Oct 28  Comment 
VANCOUVER, British Columbia, Oct. 28, 2010 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced expansion of the Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber Congenital
Hedge Fund Axial Capital Acquires More QLT Inc (QLTI)
market folly  Sep 3  Comment 
Hedge fund Axial Capital Management seems to have an insatiable appetite for shares of QLT Inc (QLTI) at current levels. Eliav Assouline and Marc Andersen's hedge fund firm have made the following acquisitions according to multiple SEC Form 4...
Hedge Fund Axial Capital Buys More QLT Inc (QLTI)
market folly  Aug 4  Comment 
Eliav Assouline and Marc Andersen's hedge fund Axial Capital Management just filed a Form 4 with the SEC regarding shares of QLT Inc (QLTI). Per the filing, Axial purchased 37,226 shares of QLTI at $5.72 per share. This brings their cumulative...




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Qlt_Inc_(QLT)"
Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki